Fundraising Fox
NuShores Biosciences
Little Rock, US · Founded 2014 · Arkansas LLC
Find your way into NuShores Biosciences
Sign up to see every warm intro you have to NuShores Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NuShores Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
Founders & leadership
NuShores Biosciences was founded in 2014 by Alexandru S. Biris, Andrew G. Kumpuris, and David E. Anderson.
Reported raises · per SEC filings
Form D private placements$2.6M disclosed across 2 rounds · 2017–2020
▶$1.5MraisedMar 2022 · 4 investors · BiotechnologyRule 506(b)
- Sharon BallardExecutive Officer, Director
- Alex BirisExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $1.5M
- Minimum investment
- $50K
- First sale
- Jul 2020
- Incorporated
- Limited Liability Company, Arkansas
- Federal exemptions
- 06b
▶$1.1MraisedJan 2019 · 8 investors · BiotechnologyRule 506(b)
- Sharon BallardExecutive Officer, Director
- Alex S. BirisExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- First sale
- Apr 2017
- Incorporated
- Limited Liability Company, Arkansas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as NuShores Biosciences.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does NuShores Biosciences do?
- NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
- Who founded NuShores Biosciences?
- NuShores Biosciences was founded by Alexandru S. Biris, Andrew G. Kumpuris, David E. Anderson in 2014.
- How much funding has NuShores Biosciences raised?
- NuShores Biosciences has disclosed $2.6M raised across 2 rounds.
- Where is NuShores Biosciences headquartered?
- NuShores Biosciences is headquartered in Little Rock, US.